Key points are not available for this paper at this time.
A new secondary prevention trial in older people with amyloid accumulation at high risk for Alzheimer's disease dementia should provide insights into whether anti-amyloid therapy can delay cognitive decline.
Building similarity graph...
Analyzing shared references across papers
Loading...
Reisa A. Sperling
Dorene M. Rentz
Keith A. Johnson
Science Translational Medicine
Harvard University
University of Pennsylvania
Brigham and Women's Hospital
Building similarity graph...
Analyzing shared references across papers
Loading...
Sperling et al. (Wed,) studied this question.
www.synapsesocial.com/papers/69d963b3da3af5b1d08366d5 — DOI: https://doi.org/10.1126/scitranslmed.3007941